UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026899
Receipt number R000030859
Scientific Title Observation and evaluation of skin and subcutaneous tissue using ultrasonic examination equipment for lymphedema
Date of disclosure of the study information 2017/05/01
Last modified on 2020/01/21 13:47:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observation and evaluation of skin and subcutaneous tissue using ultrasonic examination equipment for lymphedema

Acronym

Observation and evaluation of skin and subcutaneous tissue using ultrasonic examination equipment for lymphedema

Scientific Title

Observation and evaluation of skin and subcutaneous tissue using ultrasonic examination equipment for lymphedema

Scientific Title:Acronym

Observation and evaluation of skin and subcutaneous tissue using ultrasonic examination equipment for lymphedema

Region

Japan


Condition

Condition

lymphedema

Classification by specialty

Surgery in general Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The main purpose of this research is to use ultrasonic examination equipment with high versatility and widely used to early diagnosis, severity assessment, treatment effect judgment of patients with limb lymphedema, ultrasonic It is to prepare appropriate criteria for limb lymphedema by test equipment. If this demonstrates the usefulness of mild ultrasonography of invasion of lymphedema, this will lead to reducing the physical and mental burden of the patient in routine practice.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

From the consent acquisition until the end of the research period, obtain the following image findings. Simple ultrasound examination (B mode): presence / absence of boundary line at lower edge of dermis, continuity of fascia. Simple ultrasonography (elastography): Hardness of subcutaneous tissue.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

1. We performed lymphoscintigraphy (SPECT / CT) or ICG fluorescence lymphangiography according to our protocol on patients with chronic lymphedema of the extremity who had visited Yokohama City University Department of Plastic Surgery to classify the severity of lymphatic dysfunction . After acquiring consent for participation in this study, we confirm that all selection criteria are met and whether any of exclusion criteria are not met, and patients who satisfy the conditions are registered as research subjects.
2. I will listen to the subjects for physical clinical severity (circumference, volume, frequency of inflammation etc.) about lymphoedema, timing of onset of edema, years since onset, past treatment history etc.
3. Determine the content of conservative treatment according to severity of lymph dysfunction.
4. Evaluate the following items with ultrasonic inspection equipment before the start of preservative treatment and at the time when the content of preserved preservative treatment is reached.
* Observe the skin and subcutaneous tissue in standard mode and observe the thickness measurement and change in brightness.
* Evaluate hardness change of tissue before and after treatment by using mode for evaluating hardness such as elastography and shea wave.
5. Scheduled preservation After reaching the treatment, if there is hope from the research subject, lymph venous anastomosis is performed. Among patients who underwent surgical treatment, in cases where consent on donation of subcutaneous and lymphatic vessels was obtained in a study different from this study, examination of correlation and correlation between pathological findings and ultrasonic image findings As well.

Interventions/Control_2

1. Volunteers for healthy volunteers will be publicly invited on our homepage.
2. After acquiring consent for participation in this study, we confirm that all selection criteria are met and whether any of exclusion criteria are not met, and healthy volunteers meeting the conditions are registered as research subjects.
3. Evaluate the following items with ultrasonic inspection equipment.
* Observe the skin and subcutaneous tissue in standard mode and observe the thickness measurement and change in brightness.
* Evaluate the hardness of tissue using a mode for evaluating hardness such as elastography and shea wave.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients diagnosed with limb lymphedema by lymphoscintigraphy or ICG fluorescence lymphangiography
2. Patients who are 0 to 80 years of age at the time of registration do not matter in sex.
3. Whether or not treatment history for limb lymphoedema is present does not matter.
Four. Patients with systolic blood pressure less than 160 mm Hg and diastolic blood pressure less than 100 mm Hg (internal control possible)
5. Patients with severe heart disease or lung disease
6. Uncontrollable diabetic patients (with or without treatment) with a fasting blood sugar level of 130 mg / dL or more
7. In addition, patients judged unsuitable as subjects by doctor's judgment

Key exclusion criteria

1. Patients with a history of hypersensitivity to the drugs used
2. Patients allergic to eggs and egg products
3. Patients who are pregnant, may be pregnant, or prefer pregnancy during treatment. Breastfeeding patients
Four. Patients with right and left shunts in the heart and lungs
5. Patients with severe heart disease or lung disease
6. Uncontrollable diabetic patients (with or without treatment) with a fasting blood sugar level of 130 mg / dL or more
7. In addition, patients judged unsuitable as subjects by doctor's judgment

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Maegawa Jiro

Organization

Yokohama City University, School of medicine

Division name

Department of plastic and reconstructive surgery

Zip code


Address

Fukuura 3-9, Kanazawa-ku, Yokohama City, Kanagawa Prefecture

TEL

045-787-2709

Email

prs_ycu@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Maegawa Jiro

Organization

Yokohama City University, School of medicine

Division name

Department of plastic and reconstructive surgery

Zip code


Address

Fukuura 3-9, Kanazawa-ku, Yokohama City, Kanagawa Prefecture

TEL

045-787-2709

Homepage URL


Email

prs_ycu@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 01 Day

Date of IRB

2017 Year 02 Month 21 Day

Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date

2019 Year 04 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 04 Month 07 Day

Last modified on

2020 Year 01 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030859


Research Plan
Registered date File name
2018/10/23 様式2号-1 研究計画書USG 1 (003)修正 Yb.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name